These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 4157558)

  • 41. Optimizing the management of prostate diseases: prostatitis and benign prostatic hyperplasia. Introduction.
    Nickel JC; Roehrborn CG
    BJU Int; 2008 Mar; 101 Suppl 3():1. PubMed ID: 18307677
    [No Abstract]   [Full Text] [Related]  

  • 42. [Diseases of the bladder neck gland, prostate].
    Haraldsson S
    Timarit Hjukrunarfel Isl; 1973; 49(1):20-3 passim. PubMed ID: 4121306
    [No Abstract]   [Full Text] [Related]  

  • 43. Evaluation of interleukin-8 in expressed prostatic secretion as a reliable biomarker of inflammation in benign prostatic hyperplasia.
    Liu L; Li Q; Han P; Li X; Zeng H; Zhu Y; Wei Q
    Urology; 2009 Aug; 74(2):340-4. PubMed ID: 19464042
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Urology].
    Jichlinski P; Wisard M
    Rev Med Suisse; 2009 Jan; 5(186):144-6. PubMed ID: 19238935
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Transperineal puncture drug injection in the treatment of chronic prostatitis].
    Zhang J; Yang J; He S; Zhang X
    Zhonghua Nan Ke Xue; 2004 Nov; 10(11):830-1, 835. PubMed ID: 15595684
    [TBL] [Abstract][Full Text] [Related]  

  • 46. What's new in urology.
    Atala A
    J Am Coll Surg; 2004 Sep; 199(3):446-61. PubMed ID: 15325616
    [No Abstract]   [Full Text] [Related]  

  • 47. Treatment of prostatitis.
    Stevermer JJ; Easley SK
    Am Fam Physician; 2000 May; 61(10):3015-22, 3025-6. PubMed ID: 10839552
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Advances in researches on the relationship between prostatic diseases and erectile dysfunction].
    Zhan JC; Wei AY
    Zhonghua Nan Ke Xue; 2005 Jun; 11(6):462-5. PubMed ID: 15999496
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Zinc levels in prostatic fluid of patients with prostate pathologies].
    Gómez Y; Arocha F; Espinoza F; Fernández D; Vásquez A; Granadillo V
    Invest Clin; 2007 Sep; 48(3):287-94. PubMed ID: 17853788
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Complications in the operative treatment of benign prostate diseases. Complications following prostatectomy with a different diagnosis than hyperplasia].
    Jönsson G
    Lakartidningen; 1968 Apr; 65(17):1767-70. PubMed ID: 4192630
    [No Abstract]   [Full Text] [Related]  

  • 51. Prostate disease: an overview.
    Anderson J
    Hosp Med; 1999 Oct; 60(10):698-9. PubMed ID: 10656059
    [No Abstract]   [Full Text] [Related]  

  • 52. Prostatitis and prostatodynia: their relationship to benign prostatic hypertrophy.
    Drach GW
    Urol Clin North Am; 1980 Feb; 7(1):79-88. PubMed ID: 6154991
    [No Abstract]   [Full Text] [Related]  

  • 53. [One-stage transurethral resection of the urinary bladder and the prostate in patients with superficial cancer of the urinary bladder combined with benign prostatic hyperplasia].
    Karaguzhin SG; Merinov DS; Martov AG
    Urologiia; 2005; (5):17-21. PubMed ID: 16281833
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inflammation and glandular proliferation in hyperplastic prostates: association with prostate specific antigen value.
    Banu NA; Azim FA; Kamal M; Rumi MA; Barua AR; Khan KH
    Bangladesh Med Res Counc Bull; 2001 Dec; 27(3):79-83. PubMed ID: 12197626
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Indomethacin and symptomatic relief of benign prostatic hyperplasia.
    Presti JC
    JAMA; 1995 Jan; 273(4):347. PubMed ID: 7529343
    [No Abstract]   [Full Text] [Related]  

  • 56. [Impact of prostatic benign hyperplasia and prostatic inflammation on the increase of prostate specific antigen levels].
    Ferrero Doria R; Pérez Flores D; Terrer Artes C; Guzmán Martínez-Valls PL; Morga Egea JP; Tomás Ros M; Rico Galiano JL; Sempere Gutiérrez A; Fontana Compiano LO
    Actas Urol Esp; 1997 Feb; 21(2):100-4. PubMed ID: 9214204
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Role of apoptosis and chronic prostatitis in the pathogenesis of benign prostatic hyperplasia].
    Pawlicki B; Zieliński H; Dabrowski M
    Pol Merkur Lekarski; 2004 Oct; 17(100):307-10. PubMed ID: 15690689
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Diagnosis of urinary bladder and prostate (author's transl)].
    Watanabe H
    Rinsho Hoshasen; 1980; 25(10):1147-59. PubMed ID: 6162042
    [No Abstract]   [Full Text] [Related]  

  • 59. [Cytological diagnosis of the prostate].
    Böcking A
    Urologe A; 1983 May; 22(3):134-43. PubMed ID: 6192579
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Further experience with Prostagutt in the treatment of chronic prostatitis in a health resort for urinary tract diseases].
    Feiber W
    Dtsch Med J; 1968 Aug; 19(15):527-8. PubMed ID: 5718751
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.